• Latest Posts

FMRP – the protein behind immunotherapy resistance

PACT Pharma reports data from CRISPR cancer study

Companies with exclusive rights to CRISPR diagnostic methods sign agreement

The role of long-read sequencing in validating CRISPR outcomes

Interview 17 Oct 2022

CRISPR gene editing: a key tool for counteracting climate change

Way to transform Cas-9 protein into spherical nuclear acid developed

ADVERTISEMENT

Italian study shows CRISPR/Cas9 deletion of Interleukin-30 reduces prostate cancer growth

PerkinElmer’s Horizon Discovery: the lowdown on base editing

The challenges of translating CRISPR to the clinic

CRISPR/Cas9: Challenges and outlook from an investor’s perspective

More News! 14 Oct 2022

ChristianaCare spins out new gene-editing company CorriXR Therapeutics

Growing hub Lithuania ready to welcome biotech sector to EFIB’22

ADVERTISEMENT